Chronic Pain - Pipeline Review, H1 2016

  • ID: 3714960
  • Drug Pipelines
  • 382 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • Astraea Therapeutics, LLC
  • ChironWells GmbH
  • Ensysce Biosciences Inc.
  • Kymab Limited
  • Neura Therapeutik, LLC
  • MORE
Chronic Pain - Pipeline Review, H1 2016

Summary

‘Chronic Pain - Pipeline Review, H1 2016’, provides an overview of the Chronic Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chronic Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chronic Pain and features dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Chronic Pain
- The report reviews pipeline therapeutics for Chronic Pain by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Chronic Pain therapeutics and enlists all their major and minor projects
- The report assesses Chronic Pain therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Chronic Pain

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Chronic Pain
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Chronic Pain pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • Astraea Therapeutics, LLC
  • ChironWells GmbH
  • Ensysce Biosciences Inc.
  • Kymab Limited
  • Neura Therapeutik, LLC
  • MORE
Introduction

Chronic Pain Overview

Therapeutics Development

Chronic Pain - Therapeutics under Development by Companies

Chronic Pain - Therapeutics under Investigation by Universities/Institutes

Chronic Pain - Pipeline Products Glance

Chronic Pain - Products under Development by Companies

Chronic Pain - Products under Investigation by Universities/Institutes

Chronic Pain - Companies Involved in Therapeutics Development

Chronic Pain - Therapeutics Assessment

Drug Profiles

Chronic Pain - Recent Pipeline Updates

Chronic Pain - Dormant Projects

Chronic Pain - Discontinued Products

Chronic Pain - Product Development Milestones

Appendix

List of Tables

Number of Products under Development for Chronic Pain, H1 2016

Number of Products under Development for Chronic Pain - Comparative Analysis, H1 2016

Number of Products under Development by Companies, H1 2016

Number of Products under Development by Companies, H1 2016 (Contd..1)

Number of Products under Development by Companies, H1 2016 (Contd..2)

Number of Products under Development by Companies, H1 2016 (Contd..3)

Number of Products under Development by Companies, H1 2016 (Contd..4)

Number of Products under Development by Companies, H1 2016 (Contd..5)

Number of Products under Investigation by Universities/Institutes, H1 2016

Comparative Analysis by Late Stage Development, H1 2016

Comparative Analysis by Clinical Stage Development, H1 2016

Comparative Analysis by Early Stage Development, H1 2016

Comparative Analysis by Unknown Stage Development, H1 2016

Products under Development by Companies, H1 2016

Products under Development by Companies, H1 2016 (Contd..1)

Products under Development by Companies, H1 2016 (Contd..2)

Products under Development by Companies, H1 2016 (Contd..3)

Products under Development by Companies, H1 2016 (Contd..4)

Products under Development by Companies, H1 2016 (Contd..5)

Products under Development by Companies, H1 2016 (Contd..6)

Products under Development by Companies, H1 2016 (Contd..7)

Products under Investigation by Universities/Institutes, H1 2016

Chronic Pain - Pipeline by AbbVie Inc., H1 2016

Chronic Pain - Pipeline by Acadia Pharmaceuticals Inc., H1 2016

Chronic Pain - Pipeline by Adynxx, Inc., H1 2016

Chronic Pain - Pipeline by Allergan Plc, H1 2016

Chronic Pain - Pipeline by Amorsa Therapeutics Inc., H1 2016

Chronic Pain - Pipeline by arGEN-X BV, H1 2016

Chronic Pain - Pipeline by AskAt Inc., H1 2016

Chronic Pain - Pipeline by Astellas Pharma Inc., H1 2016

Chronic Pain - Pipeline by Astraea Therapeutics, LLC, H1 2016

Chronic Pain - Pipeline by AstraZeneca Plc, H1 2016

Chronic Pain - Pipeline by Axsome Therapeutics, Inc., H1 2016

Chronic Pain - Pipeline by BioDelivery Sciences International, Inc., H1 2016

Chronic Pain - Pipeline by Biogen, Inc., H1 2016

Chronic Pain - Pipeline by Bionomics Limited, H1 2016

Chronic Pain - Pipeline by Camurus AB, H1 2016

Chronic Pain - Pipeline by Cara Therapeutics, Inc., H1 2016

Chronic Pain - Pipeline by ChironWells GmbH, H1 2016

Chronic Pain - Pipeline by Collegium Pharmaceutical, Inc., H1 2016

Chronic Pain - Pipeline by CoLucid Pharmaceuticals, Inc., H1 2016

Chronic Pain - Pipeline by Crinetics Pharmaceuticals, Inc., H1 2016

Chronic Pain - Pipeline by Cyclenium Pharma, Inc., H1 2016

Chronic Pain - Pipeline by Cytogel Pharma, LLC, H1 2016

Chronic Pain - Pipeline by Daewoong Pharmaceutical Co., Ltd., H1 2016

Chronic Pain - Pipeline by Daiichi Sankyo Company, Limited, H1 2016

Chronic Pain - Pipeline by Dompe Farmaceutici S.p.A., H1 2016

Chronic Pain - Pipeline by Echo Pharmaceuticals B.V., H1 2016

Chronic Pain - Pipeline by Egalet Corporation, H1 2016

Chronic Pain - Pipeline by Eli Lilly and Company, H1 2016

Chronic Pain - Pipeline by Elite Pharmaceuticals, Inc., H1 2016

Chronic Pain - Pipeline by Ensysce Biosciences Inc., H1 2016

Chronic Pain - Pipeline by Glenmark Pharmaceuticals Ltd., H1 2016

Chronic Pain - Pipeline by Grunenthal GmbH, H1 2016

Chronic Pain - Pipeline by Heron Therapeutics, Inc., H1 2016

Chronic Pain - Pipeline by INSYS Therapeutics, Inc., H1 2016

Chronic Pain - Pipeline by Johnson & Johnson, H1 2016

Chronic Pain - Pipeline by Kareus Therapeutics, SA, H1 2016

Chronic Pain - Pipeline by Kineta, Inc., H1 2016

Chronic Pain - Pipeline by Kymab Limited, H1 2016

Chronic Pain - Pipeline by Laboratorios Del Dr. Esteve S.A., H1 2016

Chronic Pain - Pipeline by Lohocla Research Corporation, H1 2016

Chronic Pain - Pipeline by Lpath, Inc., H1 2016

Chronic Pain - Pipeline by Merck & Co., Inc., H1 2016

Chronic Pain - Pipeline by Mertiva AB, H1 2016

Chronic Pain - Pipeline by Moberg Pharma AB, H1 2016

Chronic Pain - Pipeline by Mundipharma International Ltd, H1 2016

Chronic Pain - Pipeline by Nanomerics Ltd, H1 2016

Chronic Pain - Pipeline by Nektar Therapeutics, H1 2016

Chronic Pain - Pipeline by Neura Therapeutik, LLC, H1 2016

Chronic Pain - Pipeline by Orion Oyj, H1 2016

Chronic Pain - Pipeline by Pacira Pharmaceuticals, Inc., H1 2016

Chronic Pain - Pipeline by Pain Therapeutics, Inc., H1 2016

Chronic Pain - Pipeline by PeriphaGen, Inc., H1 2016

Chronic Pain - Pipeline by Pfizer Inc., H1 2016

Chronic Pain - Pipeline by Phosphagenics Limited, H1 2016

Chronic Pain - Pipeline by Prismic Pharmaceuticals, Inc., H1 2016

Chronic Pain - Pipeline by Purdue Pharma L.P., H1 2016

Chronic Pain - Pipeline by Relmada Therapeutics, Inc., H1 2016

Chronic Pain - Pipeline by Ribomic Inc., H1 2016

Chronic Pain - Pipeline by Sea4Us, H1 2016

Chronic Pain - Pipeline by Shulov Innovative Science Ltd., H1 2016

Chronic Pain - Pipeline by Syntrix Biosystems, Inc., H1 2016

Chronic Pain - Pipeline by Teva Pharmaceutical Industries Limited, H1 2016

Chronic Pain - Pipeline by Therapix Biosciences Ltd, H1 2016

Chronic Pain - Pipeline by Trevena, Inc., H1 2016

Chronic Pain - Pipeline by Yooyoung Pharmaceutical Co., Ltd., H1 2016

Chronic Pain - Pipeline by Zynerba Pharmaceuticals, Inc., H1 2016

Assessment by Monotherapy Products, H1 2016

Assessment by Combination Products, H1 2016

Number of Products by Stage and Target, H1 2016

Number of Products by Stage and Mechanism of Action, H1 2016

Number of Products by Stage and Route of Administration, H1 2016

Number of Products by Stage and Molecule Type, H1 2016

Chronic Pain Therapeutics - Recent Pipeline Updates, H1 2016

Chronic Pain - Dormant Projects, H1 2016

Chronic Pain - Dormant Projects (Contd..1), H1 2016

Chronic Pain - Dormant Projects (Contd..2), H1 2016

Chronic Pain - Dormant Projects (Contd..3), H1 2016

Chronic Pain - Dormant Projects (Contd..4), H1 2016

Chronic Pain - Dormant Projects (Contd..5), H1 2016

Chronic Pain - Dormant Projects (Contd..6), H1 2016

Chronic Pain - Dormant Projects (Contd..7), H1 2016

Chronic Pain - Dormant Projects (Contd..8), H1 2016

Chronic Pain - Discontinued Products, H1 2016

Chronic Pain - Discontinued Products (Contd..1), H1 2016

Chronic Pain - Discontinued Products (Contd..2), H1 2016

List of Figures

Number of Products under Development for Chronic Pain, H1 2016

Number of Products under Development for Chronic Pain - Comparative Analysis, H1 2016

Number of Products under Development by Companies, H1 2016

Number of Products under Investigation by Universities/Institutes, H1 2016

Comparative Analysis by Late Stage Development, H1 2016

Comparative Analysis by Clinical Stage Development, H1 2016

Comparative Analysis by Early Stage Products, H1 2016

Assessment by Monotherapy Products, H1 2016

Assessment by Combination Products, H1 2016

Number of Products by Top 10 Targets, H1 2016

Number of Products by Stage and Top 10 Targets, H1 2016

Number of Products by Top 10 Mechanism of Actions, H1 2016

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2016

Number of Products by Top 10 Routes of Administration, H1 2016

Number of Products by Stage and Top 10 Routes of Administration, H1 2016

Number of Products by Top 10 Molecule Types, H1 2016

Number of Products by Stage and Top 10 Molecule Types, H1 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
AbbVie Inc.
Acadia Pharmaceuticals Inc.
Adynxx, Inc.
Allergan Plc
Amorsa Therapeutics Inc.
arGEN-X BV
AskAt Inc.
Astellas Pharma Inc.
Astraea Therapeutics, LLC
AstraZeneca Plc
Axsome Therapeutics, Inc.
BioDelivery Sciences International, Inc.
Biogen, Inc.
Bionomics Limited
Camurus AB
Cara Therapeutics, Inc.
ChironWells GmbH
Collegium Pharmaceutical, Inc.
CoLucid Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc.
Cyclenium Pharma, Inc.
Cytogel Pharma, LLC
Daewoong Pharmaceutical Co., Ltd.
Daiichi Sankyo Company, Limited
Dompe Farmaceutici S.p.A.
Echo Pharmaceuticals B.V.
Egalet Corporation
Eli Lilly and Company
Elite Pharmaceuticals, Inc.
Ensysce Biosciences Inc.
Glenmark Pharmaceuticals Ltd.
Grunenthal GmbH
Heron Therapeutics, Inc.
INSYS Therapeutics, Inc.
Johnson & Johnson
Kareus Therapeutics, SA
Kineta, Inc.
Kymab Limited
Laboratorios Del Dr. Esteve S.A.
Lohocla Research Corporation
Lpath, Inc.
Merck & Co., Inc.
Mertiva AB
Moberg Pharma AB
Mundipharma International Ltd
Nanomerics Ltd
Nektar Therapeutics
Neura Therapeutik, LLC
Orion Oyj
Pacira Pharmaceuticals, Inc.
Pain Therapeutics, Inc.
PeriphaGen, Inc.
Pfizer Inc.
Phosphagenics Limited
Prismic Pharmaceuticals, Inc.
Purdue Pharma L.P.
Relmada Therapeutics, Inc.
Ribomic Inc.
Sea4Us
Shulov Innovative Science Ltd.
Syntrix Biosystems, Inc.
Teva Pharmaceutical Industries Limited
Therapix Biosciences Ltd
Trevena, Inc.
Yooyoung Pharmaceutical Co., Ltd.
Zynerba Pharmaceuticals, Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll